Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: SL-START - SubLingual Apomorphine Schemes of TitrAtion in Real-world Treatment
Clinical trial update for SL-START evaluating sublingual apomorphine titration schemes in real-world treatment for Parkinson disease; curren…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: SAD Study in Patients With Parkinson's Disease and Motor Fluctuations [Phase 1]
A Phase 1 single-ascending-dose study in people with Parkinson's disease and motor fluctuations is currently recruiting, sponsored by Serina…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Robotic Gait Rehabilitation in Parkinson's Disease [NA]
This clinical trial update describes an ongoing robotic gait rehabilitation study for Parkinson disease and related gait disorders.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Deep Brain Stimulation Therapy in Movement Disorders [NA]
A clinical trial is investigating deep brain stimulation therapy for movement disorders, including Parkinson's disease, and is currently rec…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease [Phase 1]
A Phase 1 clinical trial of LY4006896 is enrolling healthy volunteers and Parkinson disease patients to evaluate safety and tolerability.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: ExAblate Transcranial MRgFUS of the Subthalamic Nucleus for Treatment of Parkinson's Disease [NA]
The clinical trial evaluating ExAblate Transcranial MR-guided focused ultrasound targeting the subthalamic nucleus for Parkinson's disease h…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: rTMS Over the Dorsolateral Prefrontal Cortex for the Treatment of Impulse Control Disorders in Parkinson's Disease [NA]
A clinical trial is evaluating repetitive transcranial magnetic stimulation over the dorsolateral prefrontal cortex to treat impulse control…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
Bayer-sponsored US observational study tracking how Parkinson's disease progresses in patients who still experience movement symptoms despit…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Clinical Laboratory Evaluation of Chronic Autonomic Failure
This clinical trial update reports ongoing laboratory evaluation of chronic autonomic failure in Parkinson's disease and multiple system atr…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Effects of Cognitive Dual-Task on Gait in Parkinson's Disease
This clinical trial evaluates the effect of cognitive dual-tasking on gait in Parkinson's disease and is currently not recruiting.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Agricultural Health Study Follow-up
The Agricultural Health Study follow-up has been completed. The study tracked conditions including asthma and Parkinson's disease.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Exercise Strategies in Parkinson's Disease [NA]
A Shirley Ryan AbilityLab-sponsored clinical trial evaluating exercise strategies for Parkinson's disease is currently enrolling by invitati…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Remote Therapeutic Monitoring Exercise Tracking [NA]
This update notes a remote therapeutic monitoring and exercise-tracking clinical trial focused on Parkinson disease and multiple sclerosis. …
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: First-in-Human Single and Multiple Dose of HL-400 [Phase 1]
Update on a first-in-human Phase 1 trial of HL-400 for Parkinson disease. The study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications [Phase 3]
A Phase 3 clinical trial assessing the efficacy of CVN424 in Parkinson disease patients with motor complications is currently active but not…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Pain and Autonomic Symptoms in Parkinson's Disease and Atypical Parkinsonisms
An ongoing clinical trial sponsored by Istituti Clinici Scientifici Maugeri SpA is recruiting participants to study pain and autonomic sympt…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: At-home taVNS for Neurorehabilitation in Parkinson's Disease [NA]
Update on a clinical trial investigating at-home transcutaneous auricular vagus nerve stimulation (taVNS) for neurorehabilitation in Parkins…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Effects of Dual-Task Training on Upper Extremity Function in Parkinson's Disease [NA]
A clinical trial sponsored by Ankara University is evaluating dual-task training to improve upper-extremity function in Parkinson's disease;…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Sleep Quality, Cognition, and Disease Severity in Parkinson's Disease
A clinical trial examining sleep quality, cognition, and disease severity in Parkinson's disease. The study is currently not yet recruiting.
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Treatment of Cognitive and Sensorimotor Deficits in Parkinson's Disease With High Definition Transcranial Direct Current Stimulation [NA]
This clinical trial update describes a study evaluating high-definition transcranial direct current stimulation for cognitive and sensorimot…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: The Swedish BioFINDER Sleep Study
The Swedish BioFINDER Sleep Study is currently recruiting participants, sponsored by Skane University Hospital. It focuses on Parkinson's di…
-
FDA approval · 2026-04-15FDA Approved: DATSCAN — Supplemental Application (Medi-Physics Inc. dba GE Healthcare.)
This is a supplemental FDA approval for DATSCAN (ioflupane I-123) as a dopamine transporter imaging agent. It helps in evaluating suspected …
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: Phase 2a Study of VTX3232 in Parkinson's Disease [Phase 2]
A Phase 2a trial of VTX3232 for Parkinson's disease has completed.
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Resistant Maltodextrin for Gut Microbiome in Parkinson's Disease: Safety and Tolerability Study [Phase 2]
Phase 2 clinical trial evaluating resistant maltodextrin for safety and tolerability in Parkinson's disease related to gut microbiome modula…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Collaborative vs Non-Immersive VR in Parkinson's Rehabilitation [NA]
Trial evaluating whether collaborative versus non-immersive virtual reality improves rehabilitation outcomes in Parkinson's disease; recruit…